| Literature DB >> 30270107 |
Thomas Clouaire1, Vincent Rocher2, Anahita Lashgari3, Coline Arnould2, Marion Aguirrebengoa2, Anna Biernacka4, Magdalena Skrzypczak4, François Aymard2, Bernard Fongang5, Norbert Dojer6, Jason S Iacovoni7, Maga Rowicka5, Krzysztof Ginalski4, Jacques Côté3, Gaëlle Legube8.
Abstract
Double-strand breaks (DSBs) are extremely detrimental DNA lesions that can lead to cancer-driving mutations and translocations. Non-homologous end joining (NHEJ) and homologous recombination (HR) represent the two main repair pathways operating in the context of chromatin to ensure genome stability. Despite extensive efforts, our knowledge of DSB-induced chromatin still remains fragmented. Here, we describe the distribution of 20 chromatin features at multiple DSBs spread throughout the human genome using ChIP-seq. We provide the most comprehensive picture of the chromatin landscape set up at DSBs and identify NHEJ- and HR-specific chromatin events. This study revealed the existence of a DSB-induced monoubiquitination-to-acetylation switch on histone H2B lysine 120, likely mediated by the SAGA complex, as well as higher-order signaling at HR-repaired DSBs whereby histone H1 is evicted while ubiquitin and 53BP1 accumulate over the entire γH2AX domains.Entities:
Keywords: 53BP1; ChIP-seq; DNA double-strand breaks; DSB repair; chromatin; histone H1; histone modifications; homologous recombination; non-homologous end joining; γH2AX
Mesh:
Substances:
Year: 2018 PMID: 30270107 PMCID: PMC6202423 DOI: 10.1016/j.molcel.2018.08.020
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 19.328
Figure 1BLESS Mapping of AsiSI-Induced DSB
(A) Genome browser screenshot representing γH2AX ChIP-seq and BLESS signal at a single DSB located on human chromosome 17.
(B) Heatmap representation of the BLESS profile for the 1,211 predicted AsiSI sites in the human genome in DIvA cells untreated (−4OHT) or treated for 4 hr (+4OHT). DSBs are ordered based on decreasing read count in a 1 kb window.
(C) Boxplot representing BLESS signals (1 kb window) for the 80 cut (pink) and the 1,131 uncut (gray) AsiSI sites in untreated (−4OHT) or treated (+4OHT) DIvA cells. p values were calculated using two-sample Wilcoxon tests.
(D) Average BLESS count profile for the 80 induced DSBs before (−4OHT, gray line) and after induction (+4OHT, black line).
Figure 2Large-Scale DSB-Induced Chromatin Changes
(A) Boxplot representing the ChIP-seq enrichment ratio between 4OHT-treated and untreated DIvA cells (expressed as a log2 ratio) for 80 DSBs (upper panel) or 80 randomly picked genomic regions (lower panel) over a 1 Mb window. Boxes are colored according to p values (two-sample Wilcoxon tests) and the nature of the change.
(B) Left: Average profile of the enrichment between 4OHT-treated and untreated DIvA cells for ubiquitin and H1 over 80 DSBs in a 10 Mb window. Values are expressed as log2 ratios. Right: Average profile of γH2AX in 4OHT-treated DIvA cells.
Figure 3Narrow-Scale DSB-Induced Chromatin Changes
(A) Boxplot representing the ChIP-seq enrichment ratio between treated and untreated DIvA cells (expressed as a log2 ratio) for 80 DSBs (upper panel) or 80 randomly picked genomic regions (lower panel) over a 1 kb window. Boxes are colored according to p values (two-sample Wilcoxon tests) and the nature of the change.
(B) Average profile of the enrichment between treated and untreated DIvA cells for 12 modifications, showing significant differences between each condition over 80 DSBs in a 10 kb window. Values are expressed as log2 ratios.
Figure 4Chromatin Features Associated with HR-Prone DSBs
(A) Average profile for RAD51 ChIP-seq, XRCC4 ChIP-seq, and BLESS for 30 HR (yellow) or 30 NHEJ (gray) DSBs. HR and NHEJ DSBs were defined based upon the RAD51/XRCC4 binding ratio (see STAR Methods).
(B) Boxplot representing BLESS read count (1 kb window) around 30 HR or 30 NHEJ DSBs. p value was calculated using two-sample Wilcoxon test.
(C) Heatmap representing the XRCC4 and DNA Ligase IV ChIP-seq signals on a 40 kb window centered around all AsiSI sites, ordered based on the BLESS level.
(D) Same as (A) for DNA Ligase IV ChIP-seq.
(E) Boxplot representing the ChIP-seq read count (4 kb window) for each histone modification in untreated cells for 30 HR (yellow) and 30 NHEJ (gray) DSBs. p values were calculated using two-sample Wilcoxon test. ∗p < 0.05, ∗∗p < 0.01; p > 0.05 is not significant (ns).
(F) Circle plot representing p values (from two-sample Wilcoxon test) when comparing ChIP-seq signal for HR and NHEJ DSB using increasing window size.
Figure 5HR and NHEJ-Induced Chromatin Changes
(A) Boxplot representing the ChIP-seq enrichment ratio between treated and untreated DIvA cells (expressed as a log2 ratio) for 30 HR (upper panel) or 30 NHEJ (lower panel) over a 1 kb window. Boxes are colored according to p values (two-sample Wilcoxon tests) and the nature of the change.
(B) Same as (A) for a 1 Mb window.
Figure 6Acute Signaling at HR-Prone DSBs
(A) Genome Browser screenshots representing ChIP-seq signals for XRCC4, RAD51, γH2AX, ubiquitin, H1, and BLESS for two HR-DSBs (left) and two NHEJ DSBs (right). Data are expressed as read count (from 4OHT-treated samples) for XRCC4, RAD51, and γH2AX ChIP-seq and BLESS. Data for ubiquitin (FK2) and H1 are expressed as a log2 ratio between treated and untreated cells.
(B) Average profile for γH2AX ChIP-seq (read count in OHT treated samples), ubiquitin, and H1 (as a log2 ratio between treated and untreated cells) for 30 HR (yellow) and 30 NHEJ (gray) DSBs in a 10 Mb window.
(C) Boxplot representing ChIP-seq read count from treated cells (γH2AX) or log2 ratio between treated and untreated cells (ubiquitin [FK2] and H1) for 30 HR (yellow) or 30 NHEJ (gray) DSBs in a 1 Mb window. p values were calculated using two-sample Wilcoxon tests.
Figure 753BP1 Preferentially Accumulates at HR-Prone DSBs Specifically in G1
(A) Genome Browser screenshots representing ChIP-seq signals (from 4OHT-treated samples) for 53BP1, γH2AX, and ubiquitin.
(B) Boxplot representing 53BP1 enrichment in a 1 Mb window for 30 HR (yellow) and 30 NHEJ (gray) DSBs. p value was calculated using two-sample Wilcoxon test.
(C) Average profile for 53BP1 ChIP-seq (read count in 4OHT-treated cells) for 30 HR (yellow) and 30 NHEJ (gray) DSBs in a 1.6 Mb window (upper panel).
(D) Heatmap representing 53BP1 ChIP-seq count obtained in G1- and G2-synchronized cells as indicated, on a 1 Mb window surrounding 80 DSBs induced by AsiSI. DSBs are sorted by BLESS read counts.
(E) Boxplot representing 53BP1 enrichment in a 1 Mb window for 30 HR (yellow) and 30 NHEJ (gray) DSBs in G1- and G2-synchronized cells as indicated. p values were calculated using two-sample Wilcoxon test.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Anti-H4 | Abcam | Cat# ab7311, RRID: |
| Anti-H2B | Abcam | Cat# ab1790, RRID: |
| Anti-H3 | Abcam | Cat# ab1791, RRID: |
| Anti-H2AZ | Abcam | Cat# ab4174, RRID: |
| Anti-H1 | Abcam | Cat# ab17677, RRID: |
| Anti-macroH2A1 | Millipore | Cat# 07-219, RRID: |
| Anti-H2AZac | Abcam | Cat# ab18262, RRID: |
| Anti-H3K79me2 | Active Motif | Cat# 39143, RRID: |
| Anti-H4K20me1 | Active Motif | Cat# 39727, RRID: |
| Anti-H3K9me2 | Abcam | Cat# ab1220, RRID: |
| Anti-H3K9me3 | Abcam | Cat# ab8898, RRID: |
| Anti-H3K4me2 | Millipore | Cat# 07-030, RRID: |
| Anti-H3K36me2 | Abcam | Cat# ab9049, RRID: |
| Anti-H3K36me3 | Abcam | Cat# ab9050, RRID: |
| Anti-H4K12ac | Abcam | Cat# ab46983, RRID: |
| Anti-H4K16ac | Millipore | Cat# 07-329, RRID: |
| Anti-H3K56ac | Abcam | Cat# ab76307, RRID: |
| Anti-H4S1P | Novus | Cat# NB21-2000, RRID: |
| Anti-H4K20me2 | Abcam | Cat# ab9052, RRID: |
| Anti-H2BK120Ub | Cell Signaling | Cat# 5546, RRID: |
| Anti-H2BK120ac | Millipore | Cat# 07-564, RRID: |
| Anti-Ubiquitinylated proteins | Millipore | Cat# 04-263, RRID: |
| Anti-γH2AX | Abcam | Cat# ab81299, RRID: |
| Anti-XRCC4 | Abcam | Cat# ab145, RRID: |
| Anti-RAD51 | Santa Cruz | Cat# H-92, RRID: |
| Anti-53BP1 | Novus | Cat# NB100-305, RRID: |
| Anti-DNA Ligase IV | Genetex | Cat# GTX55592 |
| (Z)-4-Hydroxytamoxifen | Sigma | Cat# H7904 |
| Thymidine | Sigma | Cat# T1895 |
| Quick-RNA MicroPrep kit | Zymo Research | Cat# R1050 |
| qScript cDNA synthesis kit | Quanta Bio | Cat# 95047-100 |
| Lipofectamine RNAiMAX | Invitrogen | Cat# 13778075 |
| SE. Cell Line 4D-Nucleofector X Kit | Lonza | Cat# V4XC1012 |
| Raw data (ChIP-seq and BLESS) | This paper | ArrayExpress: |
| RAD51 and XRCC4 ChIP-seq | ArrayExpress | |
| RNA polymerase II S2P ChIP-seq | ArrayExpress | |
| MethylCap-seq | GEO | |
| DIvA cell | N/A | |
| U20S-ISceI GFP-RFP (NHEJ) | N/A | |
| 3xFlag-Twin-strep-tagged SUPT7L K562 | N/A | |
| U2OS | N/A | ATCC HTB-96, RRID:CVCL_0042 |
| HR-DSB1 for ChIP-qPCR | N/A | |
| HR-DSB2 for ChIP-qPCR | N/A | |
| NHEJ-DSB for ChIP-qPCR | N/A | |
| ACTB for ChIP-qPCR | This paper | N/A |
| TAF12 for ChIP-qPCR | This paper | N/A |
| siRNA siSUPT7L-46 CUACUAGACCCAACAGAAA | This paper | N/A |
| siRNA siSUPT7L-47 CUAUCACAGUUACAUGC | This paper | N/A |
| siRNA siKAT2B (PCAF) CUCUAAUCCUCACUCA | This paper | N/A |
| siRNA siKAT2A (GCN5) GCUACUACGUGACCC | This paper | N/A |
| pX330-LMNAgRNA1 | N/A | |
| pCR2.1-CloverLMNAdonor | N/A | |
| piRFP670-N1 | N/A | |
| AVS1_Puro_PGK1_3xFLAG_Twin_Strep | Addgene #68375 | |
| FastQC | N/A | |
| Bwa | N/A | |
| Samtools | N/A | |
| deepTools | N/A | |
| R | N/A | |